Publications by authors named "L B Knecht"

Background: Acknowledging the significance of both subjective and objective safety in promoting cycling, there is a need for effective measures aimed at improving cycling skills among a broader population. Hence, the aim of the current study is to evaluate and investigate the impact of online cycling training targeted at adults.

Methods: An online cycling training consisting of three modules was developed to train safe behaviour in seven prototypical safety-relevant situations.

View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's (AD) and Parkinson’s disease (PD) are major neurodegenerative disorders characterized by specific protein aggregations, with Alzheimer’s linked to amyloid-beta (Aβ) and tau, and Parkinson’s associated with alpha-synuclein (αSyn).
  • The research examined naturally occurring autoantibodies (nAbs), including IgG, IgM, and IgA, in patients with AD, PD, and dementia with Lewy bodies (DLB), revealing altered levels and affinities of these antibodies compared to healthy controls.
  • Findings indicated that AD patients had lower high-affinity anti-αSyn and anti-Aβ IgGs, while DLB patients showed increased anti-αSyn IgG but decreased Ig
View Article and Find Full Text PDF

Synucleinopathies are a group of diseases characterized by brain aggregates of α-synuclein (α-syn). The gradual accumulation of α-syn and the role of inflammation in early-stage pathogenesis remain poorly understood. We explored this interaction by inducing chronic inflammation in a common pre-clinical synucleinopathy mouse model.

View Article and Find Full Text PDF

Background: Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or older with preclinical (stage 2) disease. Whether treatment with intravenous teplizumab in patients with newly diagnosed type 1 diabetes can prevent disease progression is unknown.

Methods: In this phase 3, randomized, placebo-controlled trial, we assessed β-cell preservation, clinical end points, and safety in children and adolescents who were assigned to receive teplizumab or placebo for two 12-day courses.

View Article and Find Full Text PDF

Allelopathy is a common and important stressor that shapes plant communities and can alter soil microbiomes, yet little is known about the direct effects of allelochemical addition on bacterial and fungal communities or the potential for allelochemical-selected microbiomes to mediate plant performance responses, especially in habitats naturally structured by allelopathy. Here, we present the first community-wide investigation of microbial mediation of allelochemical effects on plant performance by testing how allelopathy affects soil microbiome structure and how these microbial changes impact germination and productivity across 13 plant species. The soil microbiome exhibited significant changes to 'core' bacterial and fungal taxa, bacterial composition, abundance of functionally important bacterial and fungal taxa, and predicted bacterial functional genes after the addition of the dominant allelochemical native to this habitat.

View Article and Find Full Text PDF